Murco Wall Products

Company History

Murco Wall Products was founded in 1952 and headquartered in Fort Worth, Texas. The company established itself as a regional manufacturer of drywall finishing materials, supplying joint compounds, texturing products, and related wall-finishing systems primarily to contractors and building supply distributors across the southern and western United States.

Throughout the postwar construction boom, Murco Wall Products competed in a market where asbestos-reinforced joint compounds were common across the industry. Asbestos — particularly chrysotile, the most widely used commercial fiber type — was routinely incorporated into joint compound formulations during this era because it improved workability, reduced shrinkage, and enhanced the product’s bonding characteristics. Murco’s product lines reflected standard industry practice of the period.

According to asbestos litigation records, Murco Wall Products continued manufacturing joint compounds and texturing materials that contained chrysotile asbestos through approximately 1977. The company’s regional distribution footprint meant its products were especially prevalent on construction jobsites throughout Texas, the Southwest, and adjacent states during the 1950s, 1960s, and into the 1970s. Murco phased out asbestos-containing formulations around 1977, consistent with broader regulatory pressure following the Environmental Protection Agency’s growing restrictions on asbestos use in building materials during that decade.

Asbestos-Containing Products

Plaintiffs alleged in multiple legal proceedings that several Murco Wall Products formulations contained chrysotile asbestos during the company’s manufacturing period from 1952 through approximately 1977. The following products have appeared in asbestos litigation records:

Murco M-100 Joint Compound

The Murco M-100 Joint Compound is the most frequently cited product in litigation filings involving this manufacturer. According to asbestos litigation records, the M-100 was produced in an asbestos-containing formulation from the company’s founding in 1952 through approximately 1977. Plaintiffs alleged that this product released respirable asbestos fibers during normal application activities, including mixing, spreading, sanding, and dry-scraping.

Murco All-Purpose Joint Compound

Court filings document that Murco’s All-Purpose Joint Compound was also among the products plaintiffs identified as containing asbestos. All-purpose joint compounds were widely used for taping, topping, and finishing coats in residential and commercial drywall construction, meaning workers applied and sanded this product through multiple stages of a typical finishing sequence — each step presenting a potential exposure event.

Murco Texture Products

According to asbestos litigation records, Murco also manufactured texturing products during the relevant period that plaintiffs alleged contained chrysotile asbestos. Texture products were applied by spray, roller, or trowel to create decorative wall and ceiling finishes. Spray application in particular was associated with the generation of airborne particulate, and in buildings where asbestos-containing texture products were applied, subsequent disturbance — during renovation, repair, or demolition — can create ongoing exposure risk even decades after original application.

Occupational Exposure

The workers most frequently identified in asbestos litigation involving Murco Wall Products products are those who performed drywall finishing and related construction trades during the 1952–1977 period. Court filings document that the following occupational groups had documented or alleged contact with Murco joint compounds and texturing materials:

Drywall Finishers and Tapers worked most directly with joint compound products, applying successive coats to seams, fasteners, and corners. Sanding between coats — typically performed by hand or with power sanders — generated substantial airborne dust. Plaintiffs alleged that when this dust contained chrysotile asbestos fibers, finishers faced repeated, sustained inhalation exposure over the course of their careers.

Painters and Texture Applicators used Murco texture products to finish wall and ceiling surfaces. Spray application of texture material in enclosed spaces created conditions in which fine particulate, including any asbestos fibers present in the formulation, could remain suspended in the air for extended periods. According to asbestos litigation records, texture applicators who worked without respiratory protection during this era frequently encountered elevated airborne dust concentrations.

Carpenters and General Construction Workers present on jobsites where drywall finishing was underway were also identified in court filings as potentially exposed bystanders. Even workers not directly handling joint compound could inhale airborne dust generated by finishing and sanding operations in the same or adjacent work areas.

Homeowners and DIY Workers who purchased Murco products for residential use were similarly situated to occupational finishers during the relevant period. Plaintiffs have alleged that product labeling of the era did not provide adequate warning of asbestos content or the hazards associated with sanding and dry-scraping joint compound.

Renovation and Demolition Workers face a distinct category of exposure. Where Murco asbestos-containing joint compound or texture products were applied to structures built or finished before 1977 and those structures are later disturbed, existing material can release fibers. Under AHERA and related federal regulations, suspect materials in older buildings are treated as potentially asbestos-containing until tested or otherwise verified. Workers disturbing such materials without appropriate controls — including wetting, HEPA filtration, and respiratory protection — may face fiber release from previously applied products.

The latency period for asbestos-related diseases — the time between initial exposure and clinical diagnosis — typically ranges from 10 to 50 years. Workers exposed to Murco products during the 1950s, 1960s, and 1970s may be receiving diagnoses today. Diseases associated with asbestos inhalation include mesothelioma, asbestosis, asbestos-related lung cancer, and pleural disease. Mesothelioma, a malignancy of the lining of the lungs, abdomen, or heart, is considered a signature asbestos disease and has no established safe exposure threshold.

Trust Fund / Legal Status

No Established Asbestos Trust Fund

Murco Wall Products does not have an established asbestos bankruptcy trust fund. Unlike some manufacturers that reorganized under Chapter 11 bankruptcy and created dedicated compensation trusts — such as those overseen under 11 U.S.C. § 524(g) — Murco Wall Products has not followed that path. Accordingly, individuals alleging injury from exposure to Murco products cannot submit claims to an administrative trust fund process.

Civil Litigation

Because no trust fund exists, legal claims involving Murco Wall Products have proceeded, according to available litigation records, through the civil court system. Plaintiffs alleged in these proceedings that Murco manufactured and distributed joint compounds and texturing products containing chrysotile asbestos and that inadequate warnings accompanied these products. Court filings document that Murco products have been named in asbestos personal injury litigation, though this reference site does not attribute findings of liability, specific verdicts, or settlement amounts to Murco Wall Products as established facts.

Individuals pursuing claims related to Murco product exposure may also have potential claims against other parties in the supply chain — including distributors, contractors, or premise owners — as well as against other manufacturers whose products were used on the same jobsites. Asbestos litigation frequently involves multiple defendants because workers were exposed to products from several manufacturers over the course of their careers.

If you or a family member worked with or near Murco Wall Products joint compounds or texture products between 1952 and 1977 — or performed renovation or demolition work on structures finished with these materials — and have since been diagnosed with mesothelioma, asbestos-related lung cancer, asbestosis, or pleural disease, the following points are relevant:

  • No Murco asbestos trust fund exists. Claims cannot be filed through an administrative compensation trust. Civil litigation is the available legal avenue for claims specifically against Murco Wall Products.
  • Other trust funds may apply. Workers are rarely exposed to a single manufacturer’s products. If you handled asbestos-containing materials from other manufacturers — insulation, flooring, ceiling tile, gaskets, or other joint compounds — separate trust fund claims may be available depending on which products you used and when.
  • Statutes of limitations apply. Deadlines for filing asbestos claims vary and are generally measured from the date of diagnosis, not the date of exposure. Consulting an attorney experienced in asbestos litigation promptly after diagnosis is important to preserve legal options.
  • Documentation of exposure is important. Employment records, union membership records, coworker testimony, product invoices, and jobsite photographs can all help establish that a specific product was present on a specific worksite. Identifying the geographic distribution of Murco products — concentrated in Texas, the Southwest, and surrounding states — may assist in locating corroborating records.

Attorneys who handle asbestos cases typically offer free consultations and work on a contingency basis, meaning no legal fees are owed unless compensation is recovered. Workers, surviving family members, and legal professionals researching exposure history involving Murco Wall Products should treat this article as a starting reference and consult qualified legal counsel for guidance specific to individual circumstances.